4//SEC Filing
Kulkarni Samarth 4
Accession 0001682019-25-000003
CIK 0001674416other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:30 PM ET
Size
9.4 KB
Accession
0001682019-25-000003
Insider Transaction Report
Form 4
Kulkarni Samarth
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Shares
2025-08-16+25,000→ 220,085 total - Sale
Common Shares
2025-08-18$58.15/sh−13,081$760,660→ 207,004 total - Exercise/Conversion
Restricted Stock Units
2025-08-16−25,000→ 0 total→ Common Shares (25,000 underlying)
Holdings
- 85,622(indirect: The Kulkarni 2023 GRAT)
Common Shares
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- [F3]This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001682019
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:30 PM ET
- Size
- 9.4 KB